Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells : calcium/calmodulin-dependent pathway
Intercellular adhesion molecule-1 (ICAM-1) is an important cell surface adhesion receptor of the immune system. Its cell surface expression on a wide variety of cells, including cancer cells, is regulated by various proinflammatory cytokines. In the present study, we investigated the role of calcium...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 1994-08, Vol.54 (15), p.4144-4149 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4149 |
---|---|
container_issue | 15 |
container_start_page | 4144 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 54 |
creator | BOUILLON, M AUDETTE, M |
description | Intercellular adhesion molecule-1 (ICAM-1) is an important cell surface adhesion receptor of the immune system. Its cell surface expression on a wide variety of cells, including cancer cells, is regulated by various proinflammatory cytokines. In the present study, we investigated the role of calcium (Ca2+) and calmodulin (CaM) in the retinoic acid and gamma-interferon (IFN-gamma) signaling in the human neuroblastoma cell line SK-N-SH for up-regulating ICAM-1 expression. A 24-h incubation in the presence of Ca(2+)-mobilizing agents (A23187 and thapsigargin) resulted in the induction of ICAM-1 expression. Both Ca(2+)-mobilizing agents stimulated ICAM-1 expression additively to IFN-gamma but not to retinoic acid, suggesting that IFN-gamma does not use Ca2+ to stimulate ICAM-1, whereas retinoic acid might use it in part. As a second messenger, Ca2+ can be coupled with calmodulin. Using calmodulin inhibitors (W7 and calmidazolium), we found that retinoic acid-stimulated, A23187-stimulated, and thapsigargin-stimulated but not FIN-gamma-stimulated ICAM-1 were inhibited. Calmodulin signaling elicited by retinoic acid was an early event occurring within the first h of retinoic acid treatment, providing evidence that they may both be coupled to regulate gene expression. Using a novel CaM kinase II inhibitor, KN-62, we demonstrated that retinoic acid stimulated ICAM-1 expression in a CaM kinase II-dependent fashion. The mechanisms whereby CaM kinase II mediates retinoic acid activity on ICAM-1 expression remain to be elucidated. |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_76594583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76594583</sourcerecordid><originalsourceid>FETCH-LOGICAL-h269t-261c6a3ca43157c555d82c38a672570cff209768855734c3789673a5687faf7a3</originalsourceid><addsrcrecordid>eNo9UE1LxDAQDaKs6-pPEHIQb8Gm-aw3EXXFRcHVcxmTlI20aW1SdA_-d7tahIHHm_fmMTN7aE4F00RxLvbRPMsyTQRX-SE6ivF9pIJmYoZmqqCMUzpH388u-dB6g8F4S2LyzVBDchb7kFxvXF2PvMdgNy76NuCmrZ0Zakcodl9d7-Jvd6z1A3kk6yXejUR8iQ3Uxg_NxYhNa4faB2Jd54J1IeEO0uYTtsfooII6upMJF-j19ubleklWT3f311crssllkUguqZHADHBGhTJCCKtzwzRIlQuVmarKs0JJrYVQjBumdCEVAyG1qqBSwBbo_C-369uPwcVUNj7uFoXg2iGWSoqCC81G4-lkHN4aZ8uu9w3023L616ifTTrE8bCqh2B8_Ldxqphmkv0AnGR09A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76594583</pqid></control><display><type>article</type><title>Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells : calcium/calmodulin-dependent pathway</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>BOUILLON, M ; AUDETTE, M</creator><creatorcontrib>BOUILLON, M ; AUDETTE, M</creatorcontrib><description>Intercellular adhesion molecule-1 (ICAM-1) is an important cell surface adhesion receptor of the immune system. Its cell surface expression on a wide variety of cells, including cancer cells, is regulated by various proinflammatory cytokines. In the present study, we investigated the role of calcium (Ca2+) and calmodulin (CaM) in the retinoic acid and gamma-interferon (IFN-gamma) signaling in the human neuroblastoma cell line SK-N-SH for up-regulating ICAM-1 expression. A 24-h incubation in the presence of Ca(2+)-mobilizing agents (A23187 and thapsigargin) resulted in the induction of ICAM-1 expression. Both Ca(2+)-mobilizing agents stimulated ICAM-1 expression additively to IFN-gamma but not to retinoic acid, suggesting that IFN-gamma does not use Ca2+ to stimulate ICAM-1, whereas retinoic acid might use it in part. As a second messenger, Ca2+ can be coupled with calmodulin. Using calmodulin inhibitors (W7 and calmidazolium), we found that retinoic acid-stimulated, A23187-stimulated, and thapsigargin-stimulated but not FIN-gamma-stimulated ICAM-1 were inhibited. Calmodulin signaling elicited by retinoic acid was an early event occurring within the first h of retinoic acid treatment, providing evidence that they may both be coupled to regulate gene expression. Using a novel CaM kinase II inhibitor, KN-62, we demonstrated that retinoic acid stimulated ICAM-1 expression in a CaM kinase II-dependent fashion. The mechanisms whereby CaM kinase II mediates retinoic acid activity on ICAM-1 expression remain to be elucidated.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>PMID: 7913411</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives ; Antineoplastic agents ; Biological and medical sciences ; Calcimycin - pharmacology ; Calcium - pharmacology ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 ; Calcium-Calmodulin-Dependent Protein Kinases - biosynthesis ; Calmodulin - antagonists & inhibitors ; Calmodulin - pharmacology ; Cell Adhesion Molecules - metabolism ; Enzyme Activation ; General aspects ; Humans ; Imidazoles - pharmacology ; Intercellular Adhesion Molecule-1 ; Interferon-gamma - pharmacology ; Isoquinolines - pharmacology ; Medical sciences ; Neuroblastoma - metabolism ; Pharmacology. Drug treatments ; Piperazines - pharmacology ; Protein Kinase C - analysis ; Sulfonamides - pharmacology ; Terpenes - pharmacology ; Thapsigargin ; Tretinoin - pharmacology ; Tumor Cells, Cultured ; Up-Regulation</subject><ispartof>Cancer research (Chicago, Ill.), 1994-08, Vol.54 (15), p.4144-4149</ispartof><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4173836$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7913411$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BOUILLON, M</creatorcontrib><creatorcontrib>AUDETTE, M</creatorcontrib><title>Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells : calcium/calmodulin-dependent pathway</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Intercellular adhesion molecule-1 (ICAM-1) is an important cell surface adhesion receptor of the immune system. Its cell surface expression on a wide variety of cells, including cancer cells, is regulated by various proinflammatory cytokines. In the present study, we investigated the role of calcium (Ca2+) and calmodulin (CaM) in the retinoic acid and gamma-interferon (IFN-gamma) signaling in the human neuroblastoma cell line SK-N-SH for up-regulating ICAM-1 expression. A 24-h incubation in the presence of Ca(2+)-mobilizing agents (A23187 and thapsigargin) resulted in the induction of ICAM-1 expression. Both Ca(2+)-mobilizing agents stimulated ICAM-1 expression additively to IFN-gamma but not to retinoic acid, suggesting that IFN-gamma does not use Ca2+ to stimulate ICAM-1, whereas retinoic acid might use it in part. As a second messenger, Ca2+ can be coupled with calmodulin. Using calmodulin inhibitors (W7 and calmidazolium), we found that retinoic acid-stimulated, A23187-stimulated, and thapsigargin-stimulated but not FIN-gamma-stimulated ICAM-1 were inhibited. Calmodulin signaling elicited by retinoic acid was an early event occurring within the first h of retinoic acid treatment, providing evidence that they may both be coupled to regulate gene expression. Using a novel CaM kinase II inhibitor, KN-62, we demonstrated that retinoic acid stimulated ICAM-1 expression in a CaM kinase II-dependent fashion. The mechanisms whereby CaM kinase II mediates retinoic acid activity on ICAM-1 expression remain to be elucidated.</description><subject>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Calcimycin - pharmacology</subject><subject>Calcium - pharmacology</subject><subject>Calcium-Calmodulin-Dependent Protein Kinase Type 2</subject><subject>Calcium-Calmodulin-Dependent Protein Kinases - biosynthesis</subject><subject>Calmodulin - antagonists & inhibitors</subject><subject>Calmodulin - pharmacology</subject><subject>Cell Adhesion Molecules - metabolism</subject><subject>Enzyme Activation</subject><subject>General aspects</subject><subject>Humans</subject><subject>Imidazoles - pharmacology</subject><subject>Intercellular Adhesion Molecule-1</subject><subject>Interferon-gamma - pharmacology</subject><subject>Isoquinolines - pharmacology</subject><subject>Medical sciences</subject><subject>Neuroblastoma - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Piperazines - pharmacology</subject><subject>Protein Kinase C - analysis</subject><subject>Sulfonamides - pharmacology</subject><subject>Terpenes - pharmacology</subject><subject>Thapsigargin</subject><subject>Tretinoin - pharmacology</subject><subject>Tumor Cells, Cultured</subject><subject>Up-Regulation</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UE1LxDAQDaKs6-pPEHIQb8Gm-aw3EXXFRcHVcxmTlI20aW1SdA_-d7tahIHHm_fmMTN7aE4F00RxLvbRPMsyTQRX-SE6ivF9pIJmYoZmqqCMUzpH388u-dB6g8F4S2LyzVBDchb7kFxvXF2PvMdgNy76NuCmrZ0Zakcodl9d7-Jvd6z1A3kk6yXejUR8iQ3Uxg_NxYhNa4faB2Jd54J1IeEO0uYTtsfooII6upMJF-j19ubleklWT3f311crssllkUguqZHADHBGhTJCCKtzwzRIlQuVmarKs0JJrYVQjBumdCEVAyG1qqBSwBbo_C-369uPwcVUNj7uFoXg2iGWSoqCC81G4-lkHN4aZ8uu9w3023L616ifTTrE8bCqh2B8_Ldxqphmkv0AnGR09A</recordid><startdate>19940801</startdate><enddate>19940801</enddate><creator>BOUILLON, M</creator><creator>AUDETTE, M</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19940801</creationdate><title>Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells : calcium/calmodulin-dependent pathway</title><author>BOUILLON, M ; AUDETTE, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h269t-261c6a3ca43157c555d82c38a672570cff209768855734c3789673a5687faf7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Calcimycin - pharmacology</topic><topic>Calcium - pharmacology</topic><topic>Calcium-Calmodulin-Dependent Protein Kinase Type 2</topic><topic>Calcium-Calmodulin-Dependent Protein Kinases - biosynthesis</topic><topic>Calmodulin - antagonists & inhibitors</topic><topic>Calmodulin - pharmacology</topic><topic>Cell Adhesion Molecules - metabolism</topic><topic>Enzyme Activation</topic><topic>General aspects</topic><topic>Humans</topic><topic>Imidazoles - pharmacology</topic><topic>Intercellular Adhesion Molecule-1</topic><topic>Interferon-gamma - pharmacology</topic><topic>Isoquinolines - pharmacology</topic><topic>Medical sciences</topic><topic>Neuroblastoma - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Piperazines - pharmacology</topic><topic>Protein Kinase C - analysis</topic><topic>Sulfonamides - pharmacology</topic><topic>Terpenes - pharmacology</topic><topic>Thapsigargin</topic><topic>Tretinoin - pharmacology</topic><topic>Tumor Cells, Cultured</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOUILLON, M</creatorcontrib><creatorcontrib>AUDETTE, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOUILLON, M</au><au>AUDETTE, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells : calcium/calmodulin-dependent pathway</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>1994-08-01</date><risdate>1994</risdate><volume>54</volume><issue>15</issue><spage>4144</spage><epage>4149</epage><pages>4144-4149</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Intercellular adhesion molecule-1 (ICAM-1) is an important cell surface adhesion receptor of the immune system. Its cell surface expression on a wide variety of cells, including cancer cells, is regulated by various proinflammatory cytokines. In the present study, we investigated the role of calcium (Ca2+) and calmodulin (CaM) in the retinoic acid and gamma-interferon (IFN-gamma) signaling in the human neuroblastoma cell line SK-N-SH for up-regulating ICAM-1 expression. A 24-h incubation in the presence of Ca(2+)-mobilizing agents (A23187 and thapsigargin) resulted in the induction of ICAM-1 expression. Both Ca(2+)-mobilizing agents stimulated ICAM-1 expression additively to IFN-gamma but not to retinoic acid, suggesting that IFN-gamma does not use Ca2+ to stimulate ICAM-1, whereas retinoic acid might use it in part. As a second messenger, Ca2+ can be coupled with calmodulin. Using calmodulin inhibitors (W7 and calmidazolium), we found that retinoic acid-stimulated, A23187-stimulated, and thapsigargin-stimulated but not FIN-gamma-stimulated ICAM-1 were inhibited. Calmodulin signaling elicited by retinoic acid was an early event occurring within the first h of retinoic acid treatment, providing evidence that they may both be coupled to regulate gene expression. Using a novel CaM kinase II inhibitor, KN-62, we demonstrated that retinoic acid stimulated ICAM-1 expression in a CaM kinase II-dependent fashion. The mechanisms whereby CaM kinase II mediates retinoic acid activity on ICAM-1 expression remain to be elucidated.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>7913411</pmid><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 1994-08, Vol.54 (15), p.4144-4149 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_76594583 |
source | MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals |
subjects | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives Antineoplastic agents Biological and medical sciences Calcimycin - pharmacology Calcium - pharmacology Calcium-Calmodulin-Dependent Protein Kinase Type 2 Calcium-Calmodulin-Dependent Protein Kinases - biosynthesis Calmodulin - antagonists & inhibitors Calmodulin - pharmacology Cell Adhesion Molecules - metabolism Enzyme Activation General aspects Humans Imidazoles - pharmacology Intercellular Adhesion Molecule-1 Interferon-gamma - pharmacology Isoquinolines - pharmacology Medical sciences Neuroblastoma - metabolism Pharmacology. Drug treatments Piperazines - pharmacology Protein Kinase C - analysis Sulfonamides - pharmacology Terpenes - pharmacology Thapsigargin Tretinoin - pharmacology Tumor Cells, Cultured Up-Regulation |
title | Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells : calcium/calmodulin-dependent pathway |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T23%3A20%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Retinoic%20acid-stimulated%20intercellular%20adhesion%20molecule-1%20expression%20on%20SK-N-SH%20cells%20:%20calcium/calmodulin-dependent%20pathway&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=BOUILLON,%20M&rft.date=1994-08-01&rft.volume=54&rft.issue=15&rft.spage=4144&rft.epage=4149&rft.pages=4144-4149&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E76594583%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76594583&rft_id=info:pmid/7913411&rfr_iscdi=true |